1. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet (London, England) 2018, 392, 1789-1858, doi:10.1016/s0140-6736(18)32279-7.
2. Kulik, L.; El-Serag, H.B. Epidemiology and Management of Hepatocellular Carcinoma. Gastroenterology 2019, 156, doi:10.1053/j.gastro.2018.08.065.
3. Schweitzer, A.; Horn, J.; Mikolajczyk, R.; Krause, G.; Ott, J. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet (London, England) 2015, 386, 1546-1555, doi:10.1016/s0140-6736(15)61412-x.
4. Kim, S.R.; Kudo, M.; Hino, O.; Han, K.H.; Chung, Y.H.; Lee, H.S. Epidemiology of hepatocellular carcinoma in Japan and Korea. A review. Oncology 2008, 75 Suppl 1, 13-16, doi:10.1159/000173419.
5. Liu, Z.; Jiang, Y.; Yuan, H.; Fang, Q.; Cai, N.; Suo, C.; Jin, L.; Zhang, T.; Chen, X. The trends in incidence of primary liver cancer caused by specific etiologies: Results from the Global Burden of Disease Study 2016 and implications for liver cancer prevention. Journal of hepatology 2019, 70, 674-683, doi:10.1016/j.jhep.2018.12.001.
6. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet (London, England) 2020, 396, 1223-1249, doi:10.1016/s0140-6736(20)30752-2.
7. The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Psychiatry 2018, 5, doi:10.1016/S2215-0366(18)30337-7.
8. Deng, Y.; Zhao, P.; Zhou, L.; Xiang, D.; Hu, J.; Liu, Y.; Ruan, J.; Ye, X.; Zheng, Y.; Yao, J., et al. Epidemiological trends of tracheal, bronchus, and lung cancer at the global, regional, and national levels: a population-based study. Journal of hematology & oncology 2020, 13, 98, doi:10.1186/s13045-020-00915-0.
9. Bertuccio, P.; Turati, F.; Carioli, G.; Rodriguez, T.; La Vecchia, C.; Malvezzi, M.; Negri, E. Global trends and predictions in hepatocellular carcinoma mortality. Journal of hepatology 2017, 67, 302-309, doi:10.1016/j.jhep.2017.03.011.
10. Spearman, C.W.; Dusheiko, G.M.; Hellard, M.; Sonderup, M. Hepatitis C. Lancet (London, England) 2019, 394, 1451-1466, doi:10.1016/S0140-6736(19)32320-7.
11. Yang, W.S.; Zeng, X.F.; Liu, Z.N.; Zhao, Q.H.; Tan, Y.T.; Gao, J.; Li, H.L.; Xiang, Y.B. Diet and liver cancer risk: a narrative review of epidemiological evidence. Br J Nutr 2020, 124, 330-340, doi:10.1017/s0007114520001208.
12. Okeke, E.; Davwar, P.M.; Roberts, L.; Sartorius, K.; Spearman, W.; Malu, A.; Duguru, M. Epidemiology of Liver Cancer in Africa: Current and Future Trends. Semin Liver Dis 2020, 40, 111-123, doi:10.1055/s-0039-3399566.
13. Li, I.; Huang, J.; Chen, J.; Wang, T.; Huang, S.; Tsay, S. Factors related to the quality of life in liver cancer patients during treatment phase: A follow-up study. European journal of cancer care 2019, 28, e13146, doi:10.1111/ecc.13146.
14. Liu, X.; Hou, Y.; Wang, X.; Yu, L.; Wang, X.; Jiang, L.; Yang, Z. Machine learning-based development and validation of a scoring system for progression-free survival in liver cancer. Hepatology international 2020, 14, 567-576, doi:10.1007/s12072-020-10046-w.
15. Kolly, P.; Knöpfli, M.; Dufour, J.-F. Effect of smoking on survival of patients with hepatocellular carcinoma. Liver Int 2017, 37, 1682-1687, doi:10.1111/liv.13466.
16. Sinn, D.H.; Kang, D.; Cho, S.J.; Paik, S.W.; Guallar, E.; Cho, J.; Gwak, G.-Y. Risk of hepatocellular carcinoma in individuals without traditional risk factors: development and validation of a novel risk score. International journal of epidemiology 2020, 10.1093/ije/dyaa089, doi:10.1093/ije/dyaa089.
17. Yang, J.; Hainaut, P.; Gores, G.; Amadou, A.; Plymoth, A.; Roberts, L. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nature reviews. Gastroenterology & hepatology 2019, 16, 589-604, doi:10.1038/s41575-019-0186-y.
18. Kim, K.; Choi, S.; Park, S.M. Association of High Body Mass Index and Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Virus Infection: A Korean Population-Based Cohort Study. JAMA oncology 2018, 4, 737-739, doi:10.1001/jamaoncol.2018.0035.
19. Utsunomiya, T.; Okamoto, M.; Kameyama, T.; Matsuyama, A.; Yamamoto, M.; Fujiwara, M.; Mori, M.; Aimitsu, S.; Ishida, T. Impact of obesity on the surgical outcome following repeat hepatic resection in Japanese patients with recurrent hepatocellular carcinoma. World J Gastroenterol 2008, 14, 1553-1558.
20. Zhang, G.; Cao, F.; Shi, L.; Ma, T.; Zhang, L. Contribution of high body mass index and alcohol use to liver cancer-related mortality: A study based on 195 countries or territories. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2020, 52, 221-231, doi:10.1016/j.dld.2019.10.012.
21. Tandon, P.; Berzigotti, A. Management of Lifestyle Factors in Individuals with Cirrhosis: A Pragmatic Review. Semin Liver Dis 2020, 40, 20-28, doi:10.1055/s-0039-1696639.
22. Melo, A.; França, E.; Malta, D.; Garcia, L.; Mooney, M.; Naghavi, M. Mortality due to cirrhosis, liver cancer, and disorders attributed to alcohol use: Global Burden of Disease in Brazil, 1990 and 2015. Revista brasileira de epidemiologia = Brazilian journal of epidemiology 2017, 10.1590/1980-5497201700050006, 61-74, doi:10.1590/1980-5497201700050006.
23. Sun, Y.; Wang, Y.; Li, M.; Cheng, K.; Zhao, X.; Zheng, Y.; Liu, Y.; Lei, S.; Wang, L. Long-term trends of liver cancer mortality by gender in urban and rural areas in China: an age-period-cohort analysis. BMJ open 2018, 8, e020490, doi:10.1136/bmjopen-2017-020490.
24. Paik, J.M.; Golabi, P.; Younossi, Y.; Mishra, A.; Younossi, Z.M. Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: The Growing Impact of Nonalcoholic Fatty Liver Disease. Hepatology (Baltimore, Md.) 2020, 10.1002/hep.31173, doi:10.1002/hep.31173.